» Articles » PMID: 20124124

Ca2+ Cycling and New Therapeutic Approaches for Heart Failure

Overview
Journal Circulation
Date 2010 Feb 4
PMID 20124124
Citations 61
Authors
Affiliations
Soon will be listed here.
Citing Articles

Association of serum magnesium and calcium with metabolic syndrome: a cross-sectional study from the Qatar-biobank.

Alsheikh R, Aldulaimi H, Hinawi R, Al-Sadi F, Al-Baker A, Alkuwari A Nutr Metab (Lond). 2025; 22(1):8.

PMID: 39885554 PMC: 11783880. DOI: 10.1186/s12986-024-00892-y.


Using a Failing Human Ventricular Cardiomyocyte Model to Re-Evaluate Ca Cycling, Voltage Dependence, and Spark Characteristics.

Alvarez J, Jafri M, Ullah A Biomolecules. 2024; 14(11).

PMID: 39595549 PMC: 11591732. DOI: 10.3390/biom14111371.


Device-therapy in chronic heart failure: Cardiac contractility modulation versus cardiac resynchronization therapy.

Yuecel G, Gaasch L, Kodeih A, Hetjens S, Yazdani B, Pfleger S ESC Heart Fail. 2024; 12(1):456-466.

PMID: 39344273 PMC: 11769612. DOI: 10.1002/ehf2.15067.


Comprehensive mendelian randomization reveals atrial fibrillation-breast cancer relationship and explores common druggable targets.

Qi F, Yang L, Chang G, Wang X, Tao G, Xiao H Front Pharmacol. 2024; 15:1435545.

PMID: 39170695 PMC: 11335625. DOI: 10.3389/fphar.2024.1435545.


Effect of different hypoglycemic drugs and insulin on the risk of new-onset atrial fibrillation in people with diabetes: a network meta-analysis.

Lv Q, Yang Y, Lv Y, Wu Q, Hou X, Li L Eur J Med Res. 2024; 29(1):399.

PMID: 39085898 PMC: 11290211. DOI: 10.1186/s40001-024-01954-w.


References
1.
Dhalla N, Das P, Sharma G . Subcellular basis of cardiac contractile failure. J Mol Cell Cardiol. 1978; 10(4):363-85. DOI: 10.1016/0022-2828(78)90384-x. View

2.
Arvanitis D, Sanoudou D, Kolokathis F, Vafiadaki E, Papalouka V, Kontrogianni-Konstantopoulos A . The Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathy. Eur Heart J. 2008; 29(20):2514-25. PMC: 2567024. DOI: 10.1093/eurheartj/ehn328. View

3.
Lezoualch F, Metrich M, Hmitou I, Duquesnes N, Morel E . Small GTP-binding proteins and their regulators in cardiac hypertrophy. J Mol Cell Cardiol. 2008; 44(4):623-32. DOI: 10.1016/j.yjmcc.2008.01.011. View

4.
Koch W, Lefkowitz R, Rockman H . Functional consequences of altering myocardial adrenergic receptor signaling. Annu Rev Physiol. 2000; 62:237-60. DOI: 10.1146/annurev.physiol.62.1.237. View

5.
Engelhardt S, Hein L, Keller U, Klambt K, Lohse M . Inhibition of Na(+)-H(+) exchange prevents hypertrophy, fibrosis, and heart failure in beta(1)-adrenergic receptor transgenic mice. Circ Res. 2002; 90(7):814-9. DOI: 10.1161/01.res.0000014966.97486.c0. View